NASDAQ · Biotechnology

Kodiak Sciences Inc (KOD) Stock

$87.63 +2.16% NASDAQ: KOD Healthcare

Valuation

MetricValue
Price$87.63
Market Cap$5.51B
P/E Ratio-22.54
P/B Ratio96.82
P/S Ratio0.00
EPS (TTM)$-4.32
52-Week High$104.00
52-Week Low$10.94
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-273.23%
ROA-94.23%
ROCE-120.77%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity1.57
Current Ratio4.67

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-267.0M$-341.0M$-277.0M$-187.0M$-234.0M
Net Profit$-267.0M$-334.0M$-260.0M$-176.0M$-230.0M
EPS$-5.16$-6.39$-4.97$-3.35$-4.32
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$904.0M$667.0M$479.0M$336.0M$352.0M
Total Liabilities$241.0M$230.0M$214.0M$185.0M$194.0M
Cash$732.0M$190.0M$286.0M$168.0M$210.0M
Borrowings$180.0M$188.0M$182.0M$70.0M$159.0M

Latest News

Kodiak CFO Sells $1 Million in Stock as Shares Surge 650%. What Investors Should Know Motley Fool · Jun 10, 2026 Kodiak Sciences (KOD) Is Down 15.4% After Strong Zenkuda GLOW2 Data And Accelerated Filing Plans Simply Wall St. · Jun 6, 2026 Kodiak Stock Rises 35% in 3 Months: Here's What You Need to Know Zacks · Jun 4, 2026 Kodiak Sciences to Present at 2026 Jefferies Global Healthcare Conference PR Newswire · May 28, 2026 Boxer Capital’s $18 Million Corvus Pharma Bet Signals Confidence in This Biotech’s Next Phase Motley Fool · May 17, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-182.0M$-206.0M$-154.0M$-117.0M$-136.0M
Investing Cash Flow$-102.0M$-384.0M$208.0M$-1.0M$-1.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$-213.0M$-541.0M$95.0M$-118.0M$42.0M
Free Cash Flow$-246.0M$-254.0M$-196.0M$-118.0M$-137.0M

Valuation & Return Ratios

MetricValue
PEG Ratio2.19
EV / EBITDA-26.72
FCF Yield-2.71%
Quick Ratio2.49
Interest Coverage—
Return 1Y651.25%
Return 3Y475.03%
Return 5Y-51.13%

About Kodiak Sciences Inc

Kodiak Sciences Inc (KOD) stock trades at $87.63 with a market capitalization of $5.51B. The stock is valued at a negative price-to-earnings (P/E) ratio of -22.54, reflecting a net loss over the last twelve months, price-to-book of 96.82, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $10.94 and $104.00, and currently trades 15.7% below its 52-week high.

On profitability, Kodiak Sciences Inc generates a return on equity (ROE) of -273.23% (negative, reflecting a net loss), return on capital employed of -120.77%.

Kodiak Sciences Inc by the numbers, 2016–2025

Between 2016 and 2025 Kodiak Sciences Inc reported revenue of $0 rising to $0. Compounded, revenue has grown —% a year over five years, —% over three, —% over the last twelve months. Net profit fell to $-230.0M.

On a trailing twelve-month basis to Jun '26, revenue is $0 and net profit $-242.0M.

Borrowings stand at $159.0M, cash from operations was $-136.0M in the latest year, positive in 0 of the last 10.

Return on equity has averaged -95.7% over five years, and was -146.5% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Kodiak Sciences Inc (KOD) — frequently asked questions

What is Kodiak Sciences Inc (KOD) stock price today?

Kodiak Sciences Inc (KOD) is currently trading at $87.63, up 2.16% today.

What is KOD P/E ratio?

Kodiak Sciences Inc's P/E ratio is -22.54. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is KOD return on equity (ROE)?

Kodiak Sciences Inc's return on equity (ROE) is -273.23%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is Kodiak Sciences Inc's market cap?

Kodiak Sciences Inc has a market capitalization of $5.51B.

Does KOD pay a dividend?

Kodiak Sciences Inc is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does KOD carry?

Kodiak Sciences Inc has a debt-to-equity ratio of 1.57. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is KOD's profit margin?

Kodiak Sciences Inc reports a net profit margin of 0.00% — the share of revenue left after every cost, including tax and interest.

What sector is KOD in?

Kodiak Sciences Inc is classified under Healthcare, in the Biotechnology industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is KOD listed on?

Kodiak Sciences Inc trades on NASDAQ under the ticker KOD.

What is KOD's 52-week range?

Over the last year Kodiak Sciences Inc has traded between $10.94 and $104.00.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens KOD currently matches

On the figures above, Kodiak Sciences Inc passes the filters for 3 of our ready-made screens, among them Stocks Under $100, Mid Cap Stocks, High Current Ratio Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Stocks Under $100Mid Cap StocksHigh Current Ratio Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.